PAVmed (PAVM) Income towards Parent Company (2016 - 2025)

PAVmed's Income towards Parent Company history runs 10 years deep, the most recent figure standing at -$2.8 million for Q4 2025.

• On a quarterly basis, Income towards Parent Company fell 341.42% year-over-year to -$2.8 million in Q4 2025; TTM through Dec 2025 was -$2.5 million, a 92.35% increase from a year earlier, with the FY2025 full-year figure at -$2.5 million, down 108.69% from the prior year.
• Income towards Parent Company climbed to -$2.8 million in Q4 2025 per PAVM's latest filing, from -$6.0 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $18.6 million in Q1 2025 and bottomed at -$29.9 million in Q3 2022.
• The 5-year median for Income towards Parent Company is -$17.4 million (2023), against an average of -$14.4 million.
• Biggest YoY gain for Income towards Parent Company was 200.6% in 2025; the steepest drop was 341.42% in 2025.
• Year by year, Income towards Parent Company stood at -$19.7 million in 2021, then declined by 24.86% to -$24.6 million in 2022, then climbed by 29.16% to -$17.4 million in 2023, then surged by 106.56% to $1.1 million in 2024, then sank by 341.42% to -$2.8 million in 2025.
• Per Business Quant, the three latest PAVM Income towards Parent Company figures stand at -$2.8 million (Q4 2025), -$6.0 million (Q3 2025), and -$12.3 million (Q2 2025).